Top Links

Articles Related to agents

Irrational Anti-Retroviral Therapy Prescription among Children Under 15 Years in Eastern Uganda

Highly Active Anti-Retroviral Therapy (HAART) has transformed HIV/AIDS into a manageable chronic illness with HIVinfected children having near-normal growth milestones as a result of virologic control and immunologic reconstitution.
View complete article: PDF  |  Full-text

Isolation, Identification, and Characterization of the Novel Antibacterial Agent Methoxyphenyl-Oxime from Streptomyces pratensis QUBC97 Isolate

Streptomyces species are medically, industrially, and microbiologically important bacteria that are found in soils and other habitats. Streptomyces isolates and QUBC97 were cultured on a new medium (CCG). Agar plug diffusion test showed antibacterial activity. N-butanol extracts analysed by silica thin layer chromatography (TLC), HPLC purified and identified by MS analysis. QUBC97 was identified based on morphology, PCR, and DNA sequencing of two loci.
View complete article: PDF  |  Full-text

Severe Bone Marrow Suppression Associated with Use of Clopidogrel

A 60 year-old male presented with fever, malaise, and myalgias. The patient was admitted 3 weeks prior for acute coronary syndrome, underwent coronary stent placement, and was started on clopidogrel.
View complete article: PDF  |  Full-text

An Introduction to the Approaches of Novel Drug Delivery Systems for Acquired Immune Deficiency Syndrome (AIDS)

The currently available anti HIV agents have several drawbacks such as short half life, low bioavailability, poor CNS penetration and retention, hepatic first pass metabolism, undesirable side effects and frequent dosing regimen.
View complete article: PDF  |  Full-text

Effects of Oxytocin and Carbetocin on Haemostatic Variables in Pregnant Women after Cesarean Section

Uterine atony is the first cause of haemorrhage at delivery. To prevent post partum major bleeding uterotonic prophylactic drugs are commonly used after caesarean section. Few studies showed an haemostatic activation after oxytocin infusion while no data are available on carbetocin.
View complete article: PDF  |  Full-text

Orally Disintegrating Tablets: A Short Review

This article summarizes the advantages of orally disintegrating tablets (ODTs) as well as critical issues during evaluation of ODTs such as bioequivalence and challenges and limitations of ODTs and finally present and the future of ODTs. ODTs have received everincreasing demand and the field has become a rapidly growing area in the pharmaceutical industry.
View complete article: PDF  |  Full-text

Nanotechnology Approaches for Antiretroviral Drugs Delivery

The development of effective drug delivery approaches for the treatment of AIDS and HIV infection is a global challenge. The advent of multidrug, highly active antiretroviral therapy (HAART), have increased the life span of HIV-infected patients.
View complete article: PDF  |  Full-text

Phase II Trial of Lower Dose Bevacizumab and Irinotecan in Relapsed High Grade Gliomas

Relapsed high-grade gliomas (HGG) respond poorly to known chemotherapeutic agents with a median survival of 3 to 6 months. Several phase II trials of Bevacizumab for salvage therapy, reported excellent response rates. The optimal dose of Bevacizumab in GBM has not been defined to date. We performed a prospective phase II trial of bevacizumab using 5 mg/kg every 2 weeks.
View complete article: PDF  |  Full-text

Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery

Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.
View complete article: PDF  |  Full-text

Perspectives and Potential Applications of Ruthenium-Based Nanocarriers for Cancer Therapy

Cancer is a highly heterogeneous disease characterised by continuous uncontrolled growth and expansion of abnormal cells. In general, in tumor cells the signalling pathways regulating cellular processes, as cell growth and division and cell to cellcommunication result strongly altered.
View complete article: PDF  |  Full-text  | Digital
 
 

New Adipocytokines

They are cytokines secreted by adipose tissue considered to be immunomodulating agents, however they can be more accurately put into the larger, growing list of adipose-derived hormones.
View complete article: PDF  |  Full-text  | Digital
 
 

Treatments for Atopic Dermatitis

Atopic dermatitis, also known as eczema, affects about 10-20% of children in the UK and about 1-3% of adults [1]. The incidence of atopic dermatitis has increased as much as 3 fold in the past 40 years
View complete article: PDF  |  Full-text  | Digital
 
 

Biocompatible Polymers and Processing Techniques in Drug Delivery and Tissue Engineering

In recent years many progress has been achieved in the biomedical and biopharmaceutical fields particularly in drug delivery and regenerative medicine. This has been possible thanks to the increased expertise in polymers chemistry as well as the advent of innovative techniques of materials manipulation that have lead to the production of new “smart” polymeric devices with peculiar propertiesable to selectively reach almost all areas of the human body, in the case of drug delivery systems, or to reduce the chemical-physical gap between human tissues and synthetic devices, in the case of tissue engineering.
View complete article: PDF  |  Full-text  | Digital
 
 

The End of the Golden Age of Antibiotics?

The discovery of a substance with antibacterial properties was expected to permanently diminish the occurrence of bacterial infections posing a threat to health and life. Since the discovery of penicillin many new groups of antibiotics have been introduced into treatment of disease in people and animals, but their excessive and frequently unjustified use, and most importantly, incorrect dosage, have led to numerous unanticipated problems in contemporary human and veterinary medicine.
View complete article: PDF  |  Full-text  | Digital
 
 

The BMBL and Biosafety Levels

Scientists began developing and publishing a series of best practices to mitigate laboratory risks in the 1970’s. These biosafety guidelines are disseminated by the Department of Health and Human Services in the publication Biosafety in Microbiological and Biomedical Laboratories (BMBL).
View complete article: PDF  |  Full-text  | Digital
 
 


Editorial Board Members Related to agents

Peng Zhan

Associate professor
School of pharmaceutical sciences
Shandong University
China

Emmanuel O. Akala

Professor
Department of Pharmaceutics
Howard University Institutional Animal Care
United States

Robert R. Redfield

Professor
Department of Immunology and Microbiology
University of Maryland
United States

Rula M. Darwish

Professor
Department of Pharmaceutical Microbiology
University of Jordan
Jordan

Sabina Fijan

Assistant Professor
Faculty of Health Sciences
University of Maribor
Slovenia

Parichat Phumkhachorn

Assistant Professor
Department of Biological Science
Ubon Ratchathani University
Thailand

Zafar K. Khan

Professor
Department of Microbiology and Immunology
Drexel University
United States

Vincenzo Cuomo

Professor
Department of Physiology and Pharmacology
Sapienza University of Rome
Italy

Donald Cairns

Professor
School of Pharmacy and Life Sciences
Robert Gordon University
United Kingdom

Tao Liu

Children's Cancer Institute
University of New South Wales
Australia
Submit Manuscript